Sesame Oil is primarily composed of oleic, linoleic, palmitic, and stearic acids and is used in a variety of cosmetics that come into contact with skin, eyes, hair, and mucous membranes. The oral LD50 of a lipstick containing Sesame Oil (10–11 %) was greater than 5 g/kg. This ingredient is neither a primary skin nor ocular irritant. A formulation containing Sesame Oil was neither a sensitizer nor a photosensitizer. Although not teratogenic, Sesame Oil increased resorptions and deciduomas in mice. Extracts of sesame seeds were not mutagenic with metabolic activation. On the basis of the information presented in the report, it is concluded that Sesame Oil is safe for use as a cosmetic ingredient.
References
1.
Anton, A.H., Serrano, A., Beyer, R.D., and Lavappa, K.S. (1974). Tetrahydrocannabinol, sesame oil, and biogenic amines. Life Sci.14(9):1741–6.
2.
Beaudoin, A.R. (1981). The failure of glutamic acid to protect the rat embryo against the action of trypan blue. Teratology23(1):95–9.
3.
Blizard, D.A. (1978). The effect of neonatal oil administration on brain weight of inbred and heterogeneous mice. Dev. Psychobiol.11(5):487–93.
4.
Blumenthal, H.T., and Rogers, J.B. (1962). Studies of guinea pig tumors. II. The induction of malignant tumors in guinea pigs by methyl-cholanthrene. Cancer Res.22:1155–62.
5.
Brown, J.L. (1983). Incomplete labeling of pharmaceuticals: A list of “inactive” ingredients. N. Engl. J. Med.309(7):439–41.
6.
Budowski, P., and Markley, K.S. (1951). The chemical and physiological properties of sesame oil. Chem. Rev.48:125–51.
7.
Bulay, O.M. (1970). The study of development of lung and skin tumors in mice exposed in utero to polycyclic hydrocarbons. Acta Med. Turc.7(1):3–38.
8.
Bulay, O.M., and Wattenberg, L.W. (1971). Carcinogenic effects of poly-cyclic hydrocarbon carcinogen administration to mice during pregnancy on the progeny. J. Natl. Cancer Inst.46(2):397–402.
9.
Checchi, A.A. (1980–1983). FDA OTC Drug Ingredient Index and Manual.
10.
CODE OF FEDERAL REGULATIONS (CFR). (1984). Title 21. Food and Drugs. Washington, D.C: U.S. Government Printing Office.
11.
COSMETIC, TOILETRY AND FRAGRANCE ASSOCIATION. (CTFA). (1972a). Primary skin irritation; test no. S3/233. CTFA code no. 3–27–1, April 16.1
12.
CTFA. (1972b). Eye irritation; test no. E14/1552. CTFA code no. 3–27–2, November 14.1
Dahl, A., and Brezinski, D. (1985). Inhibition of rabbit nasal and hepatic cytochrome P-450-dependent hexamethylphosphoramide (HMPA) N-demethylase by methylenedioxyphenyl compounds. Biochem. Pharmacol.34(5):631–6.
23.
D'Souza, C.J.M., and Ramaiah, T.R. (1980). Effect of topical application of sesame oil polymer on skin. Indian). Med. Res.72:120–7.
24.
Drill, V.A., and Lazar, P. (eds.) (1977). The chamber-scarification test for assessing irritancy of topically applied substances. In: Cutaneous Toxicity. New York: Academic Press, pp. 127–54.
25.
Estrin, N.F., Crosley, P.A., and Haynes, C.R. (eds.) (1982a). CTFA Cosmetic ingredient Dictionary, 3rd ed.Washington, D.C: The Cosmetic, Toiletry and Fragrance Association.
26.
Estrin, N.F., Haynes, C.R., and Whelan, J.M. (eds.) (1982b). CTFA Compendium of Cosmetic Ingredient Composition: Specifications/Spectra. Washington, D.C.: Cosmetic, Toiletry and Fragrance Association.
27.
Fennell, T., and Bridges, J. (1979). Structure-activity relationship for ‘safrole-type’ cytochrome P-450 induction. Biochem. Soc. Trans.7(5):1104–6.
28.
FOOD AND DRUG ADMINISTRATION (FDA) (1987). Cosmetic Product Formulation Data. Washington, D.C.
29.
FDA (1991). Cosmetic Product Formulation Data. Washington, D.C.
30.
Fujii, K., Jaffe, H., Bishop, Y., Arnold, E., Mackintosh, D., and Epstein, S. (1970). Structure-activity relations for methylenedioxyphenyl and related compounds on hepatic microsomal enzyme function, as measured by prolongation of hexobarbital narcosis and zoxazolamine paralysis in mice. Toxicol. Appl. Pharmacol.16:482–94.
31.
Ceneroso, W.M., Cain, K.T., Hoskins, J.A., Washington, W.J., and Rutledge, J.C. (1984). Pseudo dominant-lethal response in female mice treated with plant oils. Mutat. Res.129:235–41.
32.
Gosselin, R.E., Hodge, H.C., Smith, R.P., and Gleason, M.N. (1976). Clinical Toxicology of Commercial Products: Acute Poisoning, 4th ed.Baltimore: Williams and Wilkins.
33.
Hayakawa, R., Matsunaga, K., Suzuki, M., Hosokawa, K., Arima, Y., Shin, C.S., and Yoshida, M. (1987). Is sesamol present in sesame oil?Contact Derm.17:133–35.
34.
HILL TOP RESEARCH (1976a). Submission of unpublished data by CTFA. Repeated insult patch test of ten test materials; test no. 76–331–72, June 30.1
35.
HILL TOP RESEARCH (1976b). Submission of unpublished data by CTFA. Repeated insult patch test; test no. 75–867–72, January 26.
36.
HILL TOP RESEARCH (1977). Submission of unpublished data by CTFA. Repeated insult patch test of ten test materials; test no. 76–1039–72, February 22.1
37.
Hirayama, T., Yamada, N., Nohara, M., and Fukui, S. (1984). The existence of the 1,2-dicarbonyl compounds glyoxal, methyl glyoxal and diacetyl in autoxidized edible oils. J. Sci. Food Agric.35(12):1357–62.
38.
Hirose, M., Masuda, A., Imaida, K., Kagawa, M., Tsuda, H., and Ito, N. (1987). Induction of forestomach lesions in rats by oral administrations of naturally occurring antioxidants for 4 weeks. Jpn. J. Cancer Res.78(4):317–21.
39.
Hirose, M., Fukushima, S., Shirai, T., Hasegawa, R., Kato, T., Tanaka, H., Asakawa, E., and Ito, N. (1990). Stomach carcinogenicity of caffeic acid, sesamol, and catechol in rats and mice. Jpn. J. Cancer Res.81(3):207–12.
40.
Huggins, C., and Grand, L.C. (1963). Sarcoma induced remotely in rats fed 3-methylcholanthrene. Cancer Res.23(3):477–80.
41.
Jaffe, H., Fujii, K., Sengupta, M., Guerin, H., and Epstein, S. (1968). In vivo inhibition of mouse liver microsomal hydroxylating systems by methylenedioxyphenyl insecticidal synergists and related compounds. Life Sci.7(19):1051–62.
42.
Jones, L.A., and Bern, H.A. (1979). Cervicovaginal and mammary gland abnormalities in BALB/CCRGL mice treated neonatally with progesterone and estrogen, alone or in combination. Cancer Res.39(7):2560–67.
43.
Kurechi, T., Kikugawa, K., and Kato, T. (1979). C-nitrosation of sesamol and its effects on N-nitrosamine formation in vitro. Chem. Pharm. Bull. (Tokyo)27(10):2442–9.
44.
Kurechi, T., Kikugawa, K., and Nishizawa, A. (1980). Transformation of hemoglobin A into methemoglobin by sesamol. Life Sci.26(20):1675–82.
45.
Neering, H., Vitanyi, B.E., Malten, K.E., van Ketel, W.G., and van Dijk, E. (1975). Allergens in sesame oil contact dermatitis. Acta Derm. Venereol. (Stockh.)55(1):31–4.
46.
Nikitakis, J. (1988). The CTFA Cosmetic Ingredient Handbook. Washington, D.C.: CTFA, p. 370.
47.
Rockwell, P., and Raw, I. (1979). Mutagenic screening of various herbs, spices and food additives. Nutr. Cancer1(4): 10–5.
48.
Rossoff, I.S. (1974). Handbook of Veterinary Drugs. A Compendium for Research and Clinical Use. New York: Springer Publishing.
49.
Sengupta, P.M., and Roy, B.R. (1983). Aflatoxin content in edible oils and fats. J. Inst. Chem. (India)55(3):101–4.
50.
Sheppard, A.J., Iverson, J.L., and Weihrauch, J.L. (1978). Composition of selected dietary fats, oils, margarines, and butter. In: Kuksis, A. (Ed.), Fatty Acids and Glycerides. New York: Plenum Press, pp. 341–79.
51.
Svendsen, O., and Aaes-Jorgensen, T. (1979). Studies on the fate of vegetable oil after intramuscular injection into experimental animals. Acta Pharmacol. Toxicol.45(5):352–78.
52.
Swern, D. (ed.) (1979). Bailey's Industrial Oil and Fat Products, Vol. 1, 4th ed.New York: John Wiley and Sons.
53.
Szepsenwol, J., Fletcher, J., Murison, G.L., and Toro-Goyco, E. (1979a). Long term effects of delta-9-tetrahydrocan-nabinol in mice. Adv. Biosci.22/23:359–70.
54.
Szepsenwol, J., Fletcher, J., and Toro-Goyco, E. (1979b). Tumors in mice receiving subcutaneous injections of delta-9-tetrahydrocannabinol. Fed. Proc.38(3, Part 2):1450.
55.
Szepsenwol, J., Fletcher, J., and Toro-Goyco, E. (1979c). Mammary cancer in mice receiving weekly subcutaneous injections of sesame oil. Proc. Am. Assoc. Cancer Res.20: 56.
56.
Szepsenwol, J., Fletcher, J., and Casales, E.A. (1982). Adrenal cortical tumorigenesis in delta-tetrahydrocannabinol (THC) or cannabinol (CNB) treated-mice. Fed. Proc.41(3):928.
57.
Windholz, M. (ed.) (1983). The Merck Index, 10th ed.Rahway, New Jersey: Merck and Co.
